Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: A randomized, double-blind, pilot study - Kelly, D L; Gorelick, D A; Conley, R R (J Clin Psychopharmacol, 2011)